UNICYCIVE THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $1.00K, a 85.71% decline year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $2.00K, a 71.43% decline year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $7.00K, a 0.00% change year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $7.00K, a 12.50% decline year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $4.00K, a 85.19% decline from fiscal 2023.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $27.00K, a 6.90% decline from fiscal 2022.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $29.00K, a 50.85% decline from fiscal 2021.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $59.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $4.00K 10-K · filed 2026-03-30 | |
| 2024-06-30 | $1.00K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $2.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $27.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $7.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $7.00K 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $7.00K 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $29.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $7.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $8.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $7.00K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $59.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $14.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $6.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $31.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |